Stannous Fluoride
drugOn this page
Also known as OmnigelTin fluoride (snf2)
Summary
Stannous Fluoride (CHEMBL1909079) is a phase-3 clinical-stage small molecule (ATC A01AA04); indicated across 4 conditions including gingivitis and dental caries.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Small molecule
- ATC class: A01AA04
- Indications: 4 conditions
- Clinical trials: 25
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1909079 |
| Name | Stannous Fluoride |
| Type | Small molecule |
| Max phase | 3 |
| ATC | A01AA04 |
Also known as: Omnigel, Stannous fluoride, Tin fluoride (snf2), Stannous Fluoride, STANNOUS FLUORIDE
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
4 indications (3 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| gingivitis | 4 | MONDO:0002508 | MONDO:0002508 |
| dental caries | 4 | MONDO:0005276 | EFO:0003819 |
| tooth disorder | 3 | MONDO:0006999 | EFO:1001216 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 25.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 13 |
| PHASE3 | 8 |
| PHASE4 | 3 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01317446 | PHASE4 | COMPLETED | Effect of Mouthrinsing on Inflammation of the Gums. |
| NCT02731833 | PHASE4 | COMPLETED | Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity |
| NCT02923895 | PHASE4 | COMPLETED | To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH) |
| NCT07215767 | PHASE3 | RECRUITING | Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice |
| NCT00762177 | PHASE3 | COMPLETED | Investigate Oral Bacteria in Adult Population |
| NCT01592851 | PHASE3 | COMPLETED | Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity |
| NCT01592864 | PHASE3 | COMPLETED | The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity |
| NCT01827670 | PHASE3 | COMPLETED | Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity |
| NCT02832375 | PHASE3 | COMPLETED | Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity |
| NCT03072719 | PHASE3 | COMPLETED | The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity |
| NCT04123665 | PHASE3 | COMPLETED | A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride |
| NCT03943095 | PHASE2 | COMPLETED | Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity |
| NCT02750943 | Not specified | COMPLETED | Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease |
| NCT02752958 | Not specified | COMPLETED | Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health |
| NCT02768194 | Not specified | COMPLETED | Dentine Tubule Occlusion Assessment in a Modified in Situ Model |
| NCT02841839 | Not specified | COMPLETED | A Study to Evaluate Sampling Methods for Subgingival Plaque |
| NCT02861664 | Not specified | COMPLETED | Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity |
| NCT02924350 | Not specified | COMPLETED | The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH) |
| NCT02937636 | Not specified | COMPLETED | To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population |
| NCT03160703 | Not specified | COMPLETED | Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices |
| NCT03296657 | Not specified | COMPLETED | Analysis of Stannous Fluoride in GCF and Subgingival Plaque |
| NCT05326373 | Not specified | COMPLETED | Stannous Fluoride and Gingivitis |
| NCT05483062 | Not specified | COMPLETED | Effectiveness of Toothpaste Containing the Active Ingredient of Galla Chinensis Extract on Treating Dentin Hypersensitivity |
| NCT06045026 | Not specified | COMPLETED | A Real-World Evidence Study Evaluating Oral Health Related Quality Of Life With Use Of A Stannous Fluoride Anti-Sensitivity Toothpaste For Dentin Hypersensitivity Management |
| NCT06197555 | Not specified | COMPLETED | Comparision of the Clinical Efficacy of Different Desensitizing Toothpastes |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: gingivitis, dental caries, tooth disorder